About: ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma (en) ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma (nl)
skos:prefLabel	ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma (en) ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma (nl)
name	ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma (en) ACVBP Versus ACVBP Plus Rituximab in Low Risk Localized Diffuse Large B-cell Lymphoma (nl)
title	wds:Q66028432-334DA180-9811-49BE-BA89-06C395DFCD01
title	Randomized Study of ACVBP Versus ACVBP Plus Rituximab in Previously Untreated Patients Aged From 18 to 65 Years With Low-risk Localized Diffuse Large B-cell Lymphoma (Age-adjusted IPI = 0) (en)
end time	wds:Q66028432-222696F5-85D2-489A-8211-E5A9350FF370
end time	2008-07-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q66028432-095C8C74-0B60-418D-BF3D-B3BD99BF5A64
instance of	clinical trial
start time	wds:Q66028432-97DF1787-C685-4D96-9AA7-E2B1B3ED1039
start time	2003-12-01 00:00:00Z (xsd:dateTime)
country	wds:Q66028432-5287FA99-77B8-4766-87ED-7C287D23D4A0 wds:Q66028432-771D1E19-B7B9-49D8-B208-0FEE4180F646 wds:Q66028432-C9113981-7D15-4ACD-81B9-3A51F185F0BF
country	Switzerland France Belgica metro station
research site	wds:Q66028432-59C06253-8928-4A48-A08E-7799C241D0F1 wds:Q66028432-AF010B34-F141-4A51-8C49-50C69EFAC372
research site	Institut Gustave Roussy wd:Q2944818
research intervention	wds:Q66028432-4BFDC3A6-3B05-43B3-9E6B-3496EE6D3347
research intervention	rituximab
minimum age	wds:Q66028432-558EA76C-15A7-41AB-8D3D-7494CEDA2C9A
minimum age	18 (xsd:decimal)
medical condition	wds:Q66028432-5AF97AD8-A6EC-4E26-AA81-7CB31C28578B
sponsor	wds:Q66028432-D8A3DA3D-FF44-42F2-9CEB-A338FC7AF674
medical condition	lymphoma
sponsor	Lymphoma Study Association
number of participants	wds:Q66028432-98FA7976-5CD3-45FF-9DBE-D4202DA6661B
number of participants	223 (xsd:decimal)
maximum age	wds:Q66028432-37E3BA37-1BEA-4012-BF3C-9A7DFB9536C6
maximum age	65 (xsd:decimal)
study type	wds:Q66028432-5D90D063-9D0E-421B-9EB0-3371FCC9A1ED
study type	interventional study
ClinicalTrials.gov ID	wds:Q66028432-B719279B-62A5-4C83-8192-3665E1AA4A5A
ClinicalTrials.gov ID	NCT00140660
clinical trial phase	wds:Q66028432-7B729800-DB5F-4E70-8695-EDE50633E6AC
clinical trial phase	phase III clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q66028432

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software